Growth and Plasma Amino Acids in Infants With CMPA and Treated With a Newly Innovated Amino Acid Formula

Mahidol University

Status: Active, not recruiting

Conditions: Cow Milk Allergy

Treatments: Dietary Supplement: Comparison of treatment with different amino acid formulas

Study type: Observational

Funder types: Other

Identifiers

NCT01637688

Si262/2012

Details and patient eligibility

About

The purpose of this study is to determine growth and protein status of infants with cow's milk protein allergy and treated with a newly innovated amino acid formula compared to those with a commercial amino acid formula.

Full description

Severe cases of cow's milk protein allergy are treated with the amino acid formula. The amino acid formula is composed of essential and non-essential amino acids, vegetable oils with or without MCT oil, and glucose polymer from various carbohydrate sources. Such formula is also fortified by minerals, trace elements,and vitamins.

Enrollment: 81 patients

Sex: All

Ages: 1 week to 6 months old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Singleton
• Clinical diagnosis of cow's milk protein allergy

Exclusion criteria

• Other diseases

Trial design

81 participants in 1 patient group

Amino acid formula

Description:

Comparison of growth between subjects who are fed with a newly innovated amino acid formula (NAAF) and who are fed with either Neocate or nutramigen AA.

Treatment:

Dietary Supplement: Comparison of treatment with different amino acid formulas